AU2018900204A0 - Enhanced viral delivery formulations - Google Patents
Enhanced viral delivery formulationsInfo
- Publication number
- AU2018900204A0 AU2018900204A0 AU2018900204A AU2018900204A AU2018900204A0 AU 2018900204 A0 AU2018900204 A0 AU 2018900204A0 AU 2018900204 A AU2018900204 A AU 2018900204A AU 2018900204 A AU2018900204 A AU 2018900204A AU 2018900204 A0 AU2018900204 A0 AU 2018900204A0
- Authority
- AU
- Australia
- Prior art keywords
- viral delivery
- delivery formulations
- enhanced viral
- enhanced
- formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title 1
- 230000003612 virological Effects 0.000 title 1
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19743365.9A EP3743112A4 (en) | 2018-01-23 | 2019-01-22 | Enhanced viral delivery formulation |
CA3088700A CA3088700A1 (en) | 2018-01-23 | 2019-01-22 | Enhanced viral delivery formulation |
CN201980015399.1A CN111770763A (en) | 2018-01-23 | 2019-01-22 | Enhanced viral delivery formulations |
PCT/AU2019/050037 WO2019144180A1 (en) | 2018-01-23 | 2019-01-22 | Enhanced viral delivery formulation |
AU2019210698A AU2019210698B2 (en) | 2018-01-23 | 2019-01-22 | Enhanced viral delivery formulation |
US16/936,025 US20210038660A1 (en) | 2018-01-23 | 2020-07-22 | Enhanced viral delivery formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2018900204A0 true AU2018900204A0 (en) | 2018-02-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3778036A4 (en) | Inhaler | |
EP3638215A4 (en) | Rna formulations | |
EP3582755A4 (en) | Formulations | |
EP4045480A4 (en) | Pharmaceutical formulations | |
EP3890732A4 (en) | Injectable formulations | |
EP3826515A4 (en) | Directed delivery system | |
EP4125815A4 (en) | Therapeutic compositions | |
ZA202006570B (en) | Pharmaceutical formulations | |
IL285674A (en) | Pharmaceutical formulations | |
EP3743084A4 (en) | Recombinant viral vaccines | |
EP3682016A4 (en) | Formulations for compound delivery | |
EP3773730A4 (en) | Drug delivery formulations | |
AU2018303130A1 (en) | Single-dose powder-medication inhaler | |
EP3743112A4 (en) | Enhanced viral delivery formulation | |
EP4007590A4 (en) | Formulations including dihydrohonokiol | |
EP3886820B8 (en) | Capsule formulations | |
EP3866847A4 (en) | Virus vaccine | |
EP3773728A4 (en) | Anti-infective formulations | |
EP3727418A4 (en) | Surfactant formulations for inhalation | |
IL291283A (en) | Drug delivery formulations | |
IL290356A (en) | Larazotide formulations | |
IL284691A (en) | Formulations | |
EP4037741A4 (en) | Inhaler | |
EP3746080A4 (en) | Pharmaceutical formulations | |
EP3775292A4 (en) | Virus bioresistors |